ArticleCureus2026
Association Between Diabetes Mellitus and Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) Loss-of-Function Allele Carriage Among Patients Undergoing Coronary Artery Bypass Grafting: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCytochrome P450 family 2 subfamily C member 19 (CYP2C19) loss-of-function (LOF) polymorphisms reduce the metabolic activation of clopidogrel and contribute to interindividual variability in antiplatelet response. Diabetes mellitus is associated with increased platelet reactivity and adverse cardiovascular outcomes; however, its association with CYP2C19 LOF allele carriage among patients undergoing coronary artery bypass grafting (CABG) remains incompletely understood.
objectiveThis study aimed to evaluate the association between diabetes mellitus and CYP2C19 LOF allele carriage among patients undergoing CABG and to describe the distribution of CYP2C19 genotypes and metabolizer phenotypes in this population.
methodsThis analytical cross-sectional study included 100 consecutive patients undergoing elective CABG. CYP2C19 genotyping (*1, *2, *3, and *17 alleles) was performed using real-time polymerase chain reaction. LOF allele carriage was defined as the presence of at least one reduced-function allele (*2 or *3). Because platelet function testing was not performed, the study evaluated genetically predicted reduced clopidogrel metabolism rather than laboratory-confirmed clopidogrel resistance. Associations between diabetes mellitus and LOF allele carriage were examined using multivariable logistic regression adjusted for age, sex, smoking history, hypertension, and dyslipidemia.
resultsThe mean age of participants was 58.6 ± 9.3 years, and 72% were male participants. Overall, 46 of 100 patients (46.0%) carried at least one CYP2C19 LOF allele. LOF allele carriage was more common among patients with diabetes mellitus than among those without diabetes (58.0% vs. 34.0%; odds ratio (OR), 2.68; 95% confidence interval (CI), 1.19-6.02; p = 0.016). After adjustment for potential confounders, diabetes mellitus remained independently associated with LOF allele carriage (adjusted OR, 1.95; 95% CI, 1.04-3.65; p = 0.037). Other clinical variables, including age, sex, smoking history, hypertension, and dyslipidemia, were not significantly associated with LOF allele carriage.
conclusionsIn this cross-sectional study, diabetes mellitus was associated with a higher prevalence of CYP2C19 LOF allele carriage among patients undergoing CABG. Because platelet function testing was not performed, these findings reflect genetically predicted reduced clopidogrel metabolism rather than confirmed clopidogrel resistance. Larger prospective studies incorporating platelet function testing and clinical outcome assessment are required to confirm these findings and determine their clinical significance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.